Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N S Key

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2012
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia AC L Kempton, T C Abshire, R A Deveras, et al.
Journal of Thrombosis and Haemostasis : JTH|November 14, 2014
Prospective study of sickle cell trait and venous thromboembolism incidenceA R Folsom, W Tang, N S Roetker, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 28, 2016
NHF-McMaster Guideline on Care Models for Haemophilia ManagementM Pai, N S Key, M Skinner, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 25, 2012
Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)T C Abshire, A B Federici, M T Alvárez, et al.
Thrombosis and Haemostasis|December 30, 1998
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitorsN S Key, L M Aledort, D Beardsley, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2004
Measuring circulating cell-derived microparticlesW Jy, L L Horstman, J J Jimenez, et al.
Thrombosis and Haemostasis|June 13, 2014
Rituximab for treatment of inhibitors in haemophilia A. A Phase II studyC Leissinger, C D Josephson, S Granger, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2012
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia AC L Kempton, T C Abshire, R A Deveras, et al.
Journal of Thrombosis and Haemostasis : JTH|November 14, 2014
Prospective study of sickle cell trait and venous thromboembolism incidenceA R Folsom, W Tang, N S Roetker, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 28, 2016
NHF-McMaster Guideline on Care Models for Haemophilia ManagementM Pai, N S Key, M Skinner, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 25, 2012
Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)T C Abshire, A B Federici, M T Alvárez, et al.
Thrombosis and Haemostasis|December 30, 1998
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitorsN S Key, L M Aledort, D Beardsley, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2004
Measuring circulating cell-derived microparticlesW Jy, L L Horstman, J J Jimenez, et al.
Thrombosis and Haemostasis|June 13, 2014
Rituximab for treatment of inhibitors in haemophilia A. A Phase II studyC Leissinger, C D Josephson, S Granger, et al.
Pageof 9